- Home
- ZGN vs SLNO Comparison
ZGN vs SLNO Comparison
Compare ZGN & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZGN
- SLNO
- Stock Information
- Founded
- ZGN 1910
- SLNO 1999
- Country
- ZGN Italy
- SLNO United States
- Employees
- ZGN N/A
- SLNO N/A
- Industry
- ZGN Apparel
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ZGN Consumer Discretionary
- SLNO Health Care
- Exchange
- ZGN Nasdaq
- SLNO Nasdaq
- Market Cap
- ZGN 2.0B
- SLNO 3.8B
- IPO Year
- ZGN N/A
- SLNO 2014
- Fundamental
- Price
- ZGN $8.95
- SLNO $82.27
- Analyst Decision
- ZGN Buy
- SLNO Strong Buy
- Analyst Count
- ZGN 2
- SLNO 9
- Target Price
- ZGN $8.05
- SLNO $105.11
- AVG Volume (30 Days)
- ZGN 2.0M
- SLNO 1.4M
- Earning Date
- ZGN 03-27-2025
- SLNO 08-06-2025
- Dividend Yield
- ZGN 1.57%
- SLNO N/A
- EPS Growth
- ZGN N/A
- SLNO N/A
- EPS
- ZGN 0.31
- SLNO N/A
- Revenue
- ZGN $2,015,371,157.00
- SLNO N/A
- Revenue This Year
- ZGN $0.74
- SLNO N/A
- Revenue Next Year
- ZGN $4.74
- SLNO N/A
- P/E Ratio
- ZGN $28.70
- SLNO N/A
- Revenue Growth
- ZGN 2.21
- SLNO N/A
- 52 Week Low
- ZGN $6.05
- SLNO $41.50
- 52 Week High
- ZGN $11.52
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- ZGN 54.41
- SLNO 51.33
- Support Level
- ZGN $8.84
- SLNO $79.70
- Resistance Level
- ZGN $9.13
- SLNO $90.32
- Average True Range (ATR)
- ZGN 0.29
- SLNO 3.66
- MACD
- ZGN 0.00
- SLNO -0.41
- Stochastic Oscillator
- ZGN 70.05
- SLNO 31.42
About ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.